TAP

Pristine_Hurry_4693

**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** ‏FDA Breakthrough Device Designation ‏FDA TAP program inclusion ‏FDA MDSAP certification ‏FDA IDE’s for five cancers and counting ‏FDA PHASE 3 completion in Q1 2026 ‏FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) ‏FDA approval for commercial factory in the US, with other factories built and more in planing ⁠100% tumor response rate in early FDA trials ‏Effective against all tumor types, including the most high unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… ‏Activates immune system PMDA approval in Japan ⁠55+ clinical sites worldwide (including USA, UK, Canada, France, Germany, Russia, Italy, Japan…) ‏Patents, IP and more…

Pristine_Hurry_4693

**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** ‏FDA Breakthrough Device Designation ‏FDA TAP program inclusion ‏FDA MDSAP certification ‏FDA IDE’s for five cancers and counting ‏FDA PHASE 3 completion in Q1 2026 ‏FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) ‏FDA approval for commercial factory in the US, with other factories built and more in planing ⁠100% tumor response rate in early FDA trials ‏Effective against all tumor types, including the most high unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… ‏Activates immune system PMDA approval in Japan ⁠55+ clinical sites worldwide (including USA, UK, Canada, France, Germany, Russia, Italy, Japan…) ‏Patents, IP and more…

Pristine_Hurry_4693

Great point, but three important factors change the dynamic completely. 1. They are being examined as a medical device and not a drug. Drug approvals are brutal, but a medical device has a much easier path and much higher success rate. It’s priced as a treatment (like a drug), but really the product is a device that enables treating the tumors from within with 100% response rate. 2. The PMDA approval they secured in Japan is considered more rigorous than the FDA, it’s the first time a treatment like this is approved in Japan before the US. This essentially de-risks the FDA, as it’s expected to approve as well (and the results support that). 3. They have a great relationship with the FDA, and the FDA loves them. They have a quarterly meeting with the FDA, were granted FDA Breakthrough Device Designation, got accepted into the FDA TAP program, have five simultaneous FDA IDEs approved and more.

Pristine_Hurry_4693

**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** ‏FDA Breakthrough Device Designation ‏FDA TAP program inclusion ‏FDA MDSAP certification ‏FDA IDE’s for five cancers and counting ‏FDA PHASE 3 completion in H1 2026 ‏FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) ‏FDA approval for commercial factory in the US, with other factories built and more in planing ⁠100% tumor response rate in early FDA trials ‏Effective against all tumor types, including the most high unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… ‏Activates immune system ⁠55+ clinical sites worldwide (including USA, UK, Canada, France, Germany, Russia, Italy, Japan…) ‏Patents, IP and more…

CheshireCat_1878

But surely he wouldn’t make us start drinking poopoopeepee juice? “BREAKING NEWS, PRESIDENT TRUMP ANNOUNCES ALL TAP WATER TO BE REPLACED WITH PEEPEEPOOPOO JUICE, ON THE ADVICE OF SECRETARY KENNEDY”

creemeeseason

I love the setup on CCOI into earnings this week. I own LEAPs. The stock is way oversold due to fund flows. Fiber optic networks are cool again. They're selling data centers when data centers are a hot commodity. Also, the stock got so cheap they restarted their buyback program. Also have some calls on TAP into earnings tomorrow. Stock has found a floor and BUD earnings last week prompted a nice reaction.

Pristine_Hurry_4693

**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** ‏FDA Breakthrough Device Designation ‏FDA TAP program inclusion ‏FDA MDSAP certification ‏FDA IDE’s for **five** cancers and counting ‏**FDA PHASE 3** completion in H1 2026 ‏FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) ‏FDA approval for commercial factory in the US, with other factories built and more in planing ⁠100% tumor response rate in early FDA trials ‏Effective against all tumor types, including the most high unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… ‏Activates immune system ⁠**55+ clinical sites worldwide** (including USA, UK, Canada, France, Germany, Russia, Italy, Japan…) ‏Patents, IP and more…

Pristine_Hurry_4693

**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** ‏FDA Breakthrough Device Designation ‏FDA TAP program inclusion ‏FDA MDSAP certification ‏FDA IDE’s for **five** cancers and counting ‏**FDA PHASE 3** completion in H1 2026 ‏FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) ‏FDA approval for commercial factory in the US, with other factories built and more in planing ⁠100% tumor response rate in early FDA trials ‏Effective against all tumor types, including the most high unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… ‏Activates immune system ⁠**50+ clinical sites worldwide** (including USA, UK, Canada, France, Germany, Russia, Italy, Japan…) ‏Patents, IP and more…

ContemplatingGavre

Consumer staples. Look at Conagra, TAP, STZ, etc

Pristine_Hurry_4693

The sad but beautiful thing about the cancer market is that there’s no real competition. All companies are needed and all could succeed. So while rooting for all three, my money is in DRTS. DRTS has a revolutionary cancer treatment, that could be combined with any other treatment, it’s a device and not a drug, has proven to be effective against all solid tumors tested to date (dozens), including the most high unmet needs cancer like Pancreas and GBM. And while the treatment is local (100% response rate in early FDA trials), it has proven to have an immune effect, potentially evolving into a systemic treatment as well. They are fully financed through commercialization (including completing the commercial manufacturing facility in New Hampshire), have an experienced team with past success, are an absolute FDA darling (they have 5! concurrent FDA IDEs, FDA Breakthrough Device Designation, FDA TAP program, MDSAP certification, regular meetings with the FDA and more), already started submitting the Phase 3 data for FDA approval, and are expecting PMDA approval in Japan very soon.

Budget-List-1214

We need to find SLV stocks in places people ain't looking. You know who makes silver bullets? TAP. Look into it, hot tip

Pristine_Hurry_4693

Bear case is any kind of disapproval, but this might be the most de-risked biotech on the market. DRTS has a revolutionary cancer treatment, could treat the most high unmet needs cancers (including Pancreas and GBM), it’s a one session treatment, doesn’t need any special equipment, and it’s the same for all solid tumors. It has 5 (!) trials going on, all with amazing results, the most advanced in Phase 3 and started submitting the data to the FDA. The FDA LOVES them, granted them FDA Breakthrough Device Designation, FDA TAP program, FDA MDSAP certification and so much more (all exclusive and prestigious and fast tracking). And the FDA won’t even be the first approval, the PMDA in Japan is set to approve them very soon. They have an experienced team, a strong cash position, building the commercial facilities and so much more.

ChuyMasta

My logic to buy stocks as soon as I turned 21.....which was like , ahem, several decades ago. I like computers! Microsoft. Buy I like beer. TAP. Buy Might as well do tobacco, cause college parties rule! Buy Everything runs on oil. Buy. I like McDonalds and steak restaurants! Buy buy. I like video cards on my teh PC. Who makes that shit? Buy I like videogames. Specially Nintendo. Ahh shit. Cant buy directly. Then I learned about NTDOF/Y (Lets not talk about the Wii U though) Sir, this is your retirement account. We advise against individual stocks. F U. It's my money! Ok, but dont sell until you are 60 or we get to keep half of it. Hhhhhhm

ConsistentListen8697

Someone once told me put a bunch of stocks on a dart board and picking one that way is the same as doing research to find a winner. Using this logic of not giving a f, I picked guns(SWBI), alcohol(TAP) and internet boner pills(HIMS). I made a ton off HIMS.

No_Location_4989

Alcohol kills more people than drugs, suicide, and car accidents combined, but lots of people still think it’s healthy and/or crucial for a good night out. BUD, STZ, TAP, BF.B etc

Kombucha-Krazy

You forgot the alcohol part of alcohol, tobacco and firearms. How about TAP and BUD

Pristine_Hurry_4693

**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** ‏FDA Breakthrough Device Designation ‏FDA TAP program inclusion ‏FDA MDSAP certification ‏FDA IDE’s for five cancers and counting Including ‏FDA PHASE 3 completion for one indication in H1 2026 ‏And FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) ‏FDA approval for commercial factory in the US, with other factories built and more in planing ⁠100% tumor response rate in early FDA trials ‏Effective against all tumor types, including unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… ‏Activates immune system ⁠50+ clinical sites worldwide (including USA, UK, Canada, France, Germany, Russia, Italy… and of course Japan where they are expected approval) ‏Patents, IP and more…

Pristine_Hurry_4693

**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** ‏FDA Breakthrough Device Designation ‏FDA TAP program inclusion ‏FDA MDSAP certification ‏FDA IDE’s for five cancers and counting Including ‏FDA PHASE 3 completion for one indication in H1 2026 ‏And FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) ‏FDA approval for commercial factory in the US, with other factories built and more in planing ⁠100% tumor response rate in early FDA trials ‏Effective against all tumor types, including unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… ‏Activates immune system ⁠50+ clinical sites worldwide (including USA, UK, Canada, France, Germany, Russia, Italy… and of course Japan where they are expected approval) ‏Patents, IP and more…

Pristine_Hurry_4693

**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** ‏FDA Breakthrough Device Designation ‏FDA TAP program inclusion ‏FDA MDSAP certification ‏FDA IDE’s for five cancers and counting Including ‏FDA PHASE 3 completion for one indication in H1 2026 ‏And FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) ‏FDA approval for commercial factory in the US, with other factories built and more in planing ⁠100% tumor response rate in early FDA trials ‏Effective against all tumor types, including unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… ‏Activates immune system ⁠50+ clinical sites worldwide (including USA, UK, Canada, France, Germany, Russia, Italy…) ‏Patents, IP and more…

Milkingacow420

I found TAP trading below book value. Would you trade that one?

ch0c0l8cake

Whos all in on $CAG AND $TAP?

ch0c0l8cake

$WEN $CMG $PFE $NVO $CAG $UPS $TAP $SG $WHR $TGT These are for true investors, not the fiends looking for a 10% random gain on some news overnight. Patience is key at this stage we are in with this market Collecting dividends, DCA, and avoid swing trading between companies is the key for the next 5-10 years

Pristine_Hurry_4693

**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** ‏FDA Breakthrough Device Designation ‏FDA TAP program inclusion ‏FDA MDSAP certification ‏FDA IDE’s for **five** cancers and counting ‏**FDA PHASE 3** completion for one indication in H1 2026 ‏FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) ‏FDA approval for commercial factory in the US, with other factories built and more in planing ⁠100% tumor response rate in early FDA trials ‏Effective against all tumor types, including high unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… ‏Activates immune system response ⁠**50+ clinical sites worldwide** (including USA, UK, Canada, France, Germany, Russia, Italy…) ‏Patents, IP and more…

Pristine_Hurry_4693

First of all I’m 100% with you on the beat cancer front, that’s what’s really exciting about it (it just happens to be that if it is successful at saving millions of people it will then make investors millions of dollars). And on the FDA front, the FDA loves DRTS. They just granted them their FIFTH simultaneous IDE. They awarded them with Breakthrough Device Designation. Accepted them into the TAP program. Certified them with the MDSAP. And more…

Pristine_Hurry_4693

**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** ‏FDA Breakthrough Device Designation ‏FDA TAP program inclusion ‏FDA MDSAP certification ‏FDA IDE’s for **five** cancers and counting ‏**FDA PHASE 3** completion for one indication in H1 2026 ‏FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) ‏FDA approval for commercial factory in the US, with other factories built and more in planing ⁠100% tumor response rate in early FDA trials ‏Effective against all tumor types, including unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… ‏Activates immune system response ⁠**50+ clinical sites worldwide** (including USA, UK, Canada, France, Germany, Russia, Italy…) ‏Patents, IP and more…

Pristine_Hurry_4693

**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** ‏FDA Breakthrough Device Designation ‏FDA TAP program inclusion ‏FDA MDSAP certification ‏FDA IDE’s for **five** cancers and counting ‏**FDA PHASE 3** completion for one indication in H1 2026 ‏FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) ‏FDA approval for commercial factory in the US, with other factories built and more in planing ⁠100% tumor response rate in early FDA trials ‏Effective against all tumor types, including unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… ‏Activates immune system response ⁠**50+ clinical sites worldwide** (including USA, UK, Canada, France, Germany, Russia, Italy…) ‏Patents, IP and more…

Pristine_Hurry_4693

Some seem to think that the GBM news could be a wake up call as well, and I could understand why. I don’t think the market is aware or understands that DRTS’s treatment could actually treat GBM, if that proves to be right (which it did in the earlier trials earning it the FDA Breakthrough Device Designation along with getting included in the FDA’s TAP program, and is now recruiting patients for the IDE) that could definitely get some attention as well.

Pristine_Hurry_4693

**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** ‏FDA Breakthrough Device Designation ‏FDA TAP program inclusion ‏FDA MDSAP certification ‏FDA IDE’s for **five** cancers and counting ‏**FDA PHASE 3** completion for one indication in H1 2026 ‏FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) ‏FDA approval for commercial factory in the US, with other factories built and more in planing ⁠100% tumor response rate in early FDA trials ‏Effective against all tumor types, including unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… ‏Activates immune system response ⁠**50+ clinical sites worldwide** (including USA, UK, Canada, France, Germany, Russia, Italy…) ‏Patents, IP and more…

Pristine_Hurry_4693

**DRTS’s clinical, regulatory, financial and commercial achievements and progress:** ‏FDA Breakthrough Device Designation ‏FDA TAP program inclusion ‏FDA MDSAP certification ‏FDA IDE’s for **five** cancers and counting ‏**FDA PHASE 3** completion for one indication in H1 2026 ‏FDA Phase 2 and other stages of trials going on in parallel for different indications (cancer types) ‏FDA approval for commercial factory in the US, with other factories built and more in planing ⁠100% tumor response rate in early FDA trials ‏Effective against all tumor types, including unmet needs like Pancreas, Lungs, Brain (GBM), Breast etc… ‏Activates immune system response ⁠**50+ clinical sites worldwide** (including USA, UK, Canada, France, Germany, Russia, Italy…) ‏Patents, IP and more…

Organic-Grocery

Drinking a beer. Calls on TAP

Pristine_Hurry_4693

I appreciate the genuine questions! Since it is a biotech stock, I believe the clinical trials failing, not getting FDA approval, running out of cash, and a general market crash are the biggest risks. I know I’m not necessarily supposed to counter, but for me a big part of the appeal of the stock is the risk management. The trials still might fail and there’s no way to know if and when the FDA will approve, but the results up to this day are amazing, and understanding how it works it’s basically physics that have been proven to work hundreds of time on dozens of tumors (every tumor tested has responded). The FDA has granted the treatment FDA breakthrough device designation, has accepted it into the FDA TAP program, it’s got MDSAP certification, FDA IDE’s for different cancer types, FDA approved its manufacturing facility and more so safe to say things are going well and the relationship with the FDA is a positive one. From the financial side they have runway for a few years, while the PMDA in Japan is expected to approve them to go to market very soon, and the FDA could as well for skin cancer (although their real goal is the inner organs) which could both mean it will no longer be pre-revenue.

jurassicman11

Bro real talk , fuck that school shit. We about to be in a recession worse than the Great Depression and these billionaires are dead set on taking AI to the point of replacing all human jobs. Use [this strategy](https://youtu.be/Mazdm2qNefc?si=lod_wRfYrr482f3v) on the 4H timeframe. If you would gain more financially for the time being by finishing school and getting TAP, then do it because the price of everything will continue to go up. But backtest this strategy, I’m telling you. You will make your money back as long as you follow the rules and do not trade with emotions. I believe in you bro, good luck🫡

bannedbutbackbenis

So I just forever borrowed $70 from Walmart. Three of my CC’s said chip read error. I tried, but after my 10th attempt I just walked out with my shit. Why is Walmart the only business that doesn’t TAP. Puts

Mediumcomputer

Good they removed this because the tariff goblin needs a TAP to do action if it’s a creature, that wasn’t an instant

hegorachi2

Just bought 5k worth of coors ($TAP) for the same reason. seems beat up but kind of concerned this generation seems to be lacking alcoholics lol

kenseyx

I'd love to see a statistic regarding that, but my guess would be that short ratio has not a good track record for future performance. My guess is also that the vast majority of short interest comes from long/short portfolio strategy hedge funds. In those cases the shorted securities would be chosen for certain volatility & correlation metrics in relation to their long portfolio rather than for a particular expectation in price movement. And with such strategies, trying to interpret these short ratios becomes rather pointless. If I look at the highest short ratios in my portfolio: GDX 17%, EWM 16%, BTU 11%, TAP 9%, is not what I would have expected, as there are other holdings which have much higher downside/bankruptcy risk than any of these.

spreadlove2world

thanks!!! I will check out $TAP and this omni-bank thing

Doctor_Saved

Been nibbling at TAP recently.

nateccs

you know if you look at young adults these days they aren’t drinking anywhere near kids did 20 years ago. That’s my primary thesis for alcohol stocks going down. Miller like is my favorite beer so I liked TAP. But the thing is a total slog and didn’t make me any money. I thought the better play for the GLP one was junk food , do you feel like there’s a better correlation between obesity and alcohol consumption?

LiberalAspergers

So far so good. Im pretty happy with my current portfolio. Still looking for gems among this market full of wildly overprices crap. Doing my DD on TAP and MCHB currently. Both have good potential, IMHO, but are still a little pricey for me. You find anything good lately?

AutoModerator

# DO NOT IGNORE THIS COMMENT Hello TAP12V, your comment has been removed because your account has low karma. We have this filter in place to help protect against bots, trolls, and spammers. We might approve your post if you were not spamming/trolling/etc in some time if your post is of significant quality. Please message the mods of r/shortsqueeze using [this link](https://reddit.com/message/compose/?to=/r/Shortsqueeze&subject=Content+Approval+Because+of+Low+Karma) if you believe this is in error and you DO fit the requirements. You will not be approved for telling us you are not a bot. (Please note -- It will not be approved sooner if you message us 5 minutes after it gets removed or if you message multiple times). Also, messaging us to say that you are not a bot is not qualification for this post to be approved. Please do not message us unless you have over the approved karma limit (25). If you do not know what karma is, or how to get it, check our r/newtoreddit *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/Shortsqueeze) if you have any questions or concerns.*

Pristine_Hurry_4693

DRTS is pre revenue but expecting PMDA approval in Japan before EOY. That’s a multi billion dollar life saving market. Has successfully treated a Pancreatic Cancer patient in the US as well, securing FDA breakthrough device designation and getting accepted into the FDA TAP program that is essentially a fast track to market.

Ziz23

Anyone else looking at TAP?

Pristine_Hurry_4693

I’ve already answered a different comment, so not to repeat I’ll try to add value and just say the stock already has: - FDA breakthrough device designation - FDA TAP program inclusion - FDA MDSAP certification - FDA IDE’s for several cancers - FDA trials (multiple) at phase 2 and 3 - Financial runway beyond commercialization - 2 manufacturing factories built and a 3rd and largest being built in the US - 100% tumor response rate in early FDA trials - Could treat high unmet needs cancers like Pancreatic, Lungs, Brain, Breast, etc… - Activates immune system response - 50+ clinical sites worldwide (including USA, UK, Canada, France, Germany, Russia, etc…) - Patents, IP and more… Some upcoming catalysts: They treated a Pancreatic Cancer patient initiating their IMPACT study, are approved to do the same for GBM, and are expecting PMDA approval in Japan this calendar year. Still one of the most under the radar and therefore undervalued plays in a multi hundred billion dollar life saving market.

Pristine_Hurry_4693

My pleasure, you should know they already have: - FDA breakthrough device designation - FDA TAP program inclusion - FDA MDSAP certification - FDA IDE’s for several cancers - FDA trials (multiple) at phase 2 and 3 - Financial runway beyond commercialization - 2 manufacturing factories built and a 3rd and largest being built in the US - 100% tumor response rate in early FDA trials - Could treat high unmet needs cancers like Pancreatic, Lungs, Brain, Breast, etc… - Activates immune system response - 50+ clinical sites worldwide (including USA, UK, Canada, France, Germany, Russia, etc…) - Patents, IP and more… Along with the expected PMDA approval and other clinical results Best of luck!

Organic-Grocery

Picked up a few shares of TAP (bought a 12 pack of banquets)

Pristine_Hurry_4693

My favorite pick is DRTS. The stock already has: - FDA breakthrough device designation - FDA TAP program inclusion - FDA MDSAP certification - FDA IDE’s for several cancers - FDA trials (multiple) at phase 2 and 3 - Financial runway beyond commercialization - 2 manufacturing factories built and a 3rd and largest being built in the US - 100% tumor response rate in early FDA trials - Could treat high unmet needs cancers like Pancreatic, Lungs, Brain, Breast, etc… - Activates immune system response - 50+ clinical sites worldwide (including USA, UK, Canada, France, Germany, Russia, etc…) - Patents, IP and more… This week they successfully initiated the IMPACT study by treating the first Pancreatic Cancer patient in the US, after successfully completing their trials with over 40 Pancreatic Cancer patients in Canada. Furthermore they are expecting PMDA approval in Japan this calendar year. One of the most undervalued plays in a multi hundred billion dollar life saving market.

rfpemp

Or...hear me out....just pick stock tickers with silly names like CAKE, BUD, EAT, FIZZ, PZZA, BUNZ, TAP, LUV, HOG, FUN, WOOF. Then you can make phrases with your tickers like: I just LUV to EAT PZZA and CAKE, drink some BUD and then go TAP some BUNZ with my HOG while she WOOFs. See? Stocks can be fun!

creemeeseason

At what point do the alcoholic beverage stocks become interesting? DEO actually had a decent bounce after earnings, which is a good sign. Apparently their brands are really popular outside of the US. BF.B got hammered through support the other day and has a good chance we're going to see capitulation soon. TAP looks really cheap, cheap enough that if they keep sales flat they can really turn on the buyback machine. On the whole, I think spirits are secularly stronger than beer, especially among higher income consumers.

Kachowxboxdad

Absolutely. Holding 100 shares PM, 300 MO, 100 TAP, and 100 STZ. It seems absolutely not priced in how well they’ll benefit if this happens

CommonSensei-_

TAP is gonna put weed in their beer. Problem solved

kiyomoris

Siemens is probably the most versatile, including Healthiners, Energy and Mobility ( although stuck with AG). IAG. Yes, I know. It's an airline stock but its the most versatile airline company in the world. It owns two big lions ( British and Iberia) and Aer Lingus. It is the only airline with the mission to have net zero emissions by 2050, it has a fuel deal with Microsoft, has a joint air cargo with Qatar and Malaysia airlines. It is also partially owned by the government of Qatar and I am only stating this because of funding. It is actively renewing its aircraft fleet. IAG is currently in the front line to acquire a stake in the Portuguese airline TAP. If it succeeds, it has no competition in long haul flights between EU and NA / South American countries. Novo Nordisk. Greatly undervalued. If semiglitude can indeed help with Alzheimer and Parkinson's, it opens a huge market for dementia and neurological conditions, other than diabetes and overweight individuals.

creemeeseason

Closed TAP calls a little early, but turned out to be a decent play. Sentiment was too bombed out. UFPT having a nice run. Wouldn't be surprised to get a little short squeeze out of this one. The short report was actually right, but management seems to have proven adept at navigating things and made some nice acquisitions to counter slowing organic growth. Not surprised to see ODD selling off solid earnings. It was too expensive. That said, I'd love to add more if it retests the $50 level. I'm also curious what they'll do with their cash hoard. $815 million in cash on a $3.5 billion market cap is insane.

creemeeseason

Interesting note from the TAP earnings: "As a result of the anticipated ongoing macroeconomic impacts on the industry, our lower-than-expected U.S. share performance, and higher-than-expected indirect tariff impacts on the pricing of aluminum, in particular the Midwest Premium pricing, we have adjusted our 2025 full-year top and bottom-line guidance," said Chief Executive Gavin Hattersley. Tariffs hitting can prices.

creemeeseason

I'll post on it this week possibly, but TAP has earnings Tuesday morning. I can't imagine something with much more negativity since there's been a series of really bad reports out of the brewers already. Might be interesting to grab a few calls into earnings to see where it goes.

Healthysinner34

TAP 10 PE. Cheap beer for inflation times

Healthysinner34

TAP

Healthysinner34

TAP is going to make me some money. Molson Coors is the way. I drink it and at family events and it makes they not as bad.

Pristine_Hurry_4693

Who - a company with a revolutionary cancer treatment Why - they could potentially save millions of lives and by doing so make you millions of dollars How - they have 100% tumor response rate in early FDA trials, their treatment is effective against all solid tumors including high unmet needs like pancreatic cancer, lung cancer, GBM, breast cancer and many more (dozens were tested and all responded, currently active in 50+ clinical sites worldwide including the US, Canada, France, Italy, Germany, UK, Russia and more). They have the financial runway to get to commercialization. They have manufacturing facilities. They have FDA breakthrough device designation. They have FDA TAP program inclusion. They have FDA MDSAP certification. They have FDA IDE’s and have multiple trials going on including phase 2 and 3 already. The treatment is a one time under an hour procedure, is lethal to the cancer cells while sparing healthy tissue and little to no side effects.

8bitaficionado

Molson Coors https://www.google.com/finance/quote/TAP:NYSE

East1st

TAP

Next_Discipline_2808

The ticker is $DRTS. It’s a company with a revolutionary cancer treatment, can treat high unmet needs, with 100% tumor response in early FDA clinical trials. They are already in phase 3 of their FDA trials. They also have the FDA’s breakthrough device designation. Are part of the FDA’s TAP program. Have MDSAP certification. And more… all to allow them to get to market ASAP. They are also expecting PMDA approval in Japan this quarter. They have 90+ million dollars, way more than needed to get to commercialization. Three factories (2 in the US) ready to manufacture. All tech is patented. They are treating patients (through trials) in 50+ clinical sites worldwide (US, UK, France, Russia, Japan, Canada…) There’s a lot to like with a multibillion dollar market, and almost no retail interest making it under the radar and undervalued.

LazerSmiles

If the stock goes under 300$ this week I’ll poop my pants. I have no strong opinion on TAP or Elon or Tesla. This was a trade based on Elons personality and history. Stock could go green Monday 5% so who knows 😆

libben

Retailers will not sell over these news. Elon creating TAP is just good for american people. To get a more neutral and middle ground politics based on what's good for Americans in general. Maybe monday we see some red or maybe we see green. If it dips below 300 after first hours Im just going to buy more shares and thank all the village idiots who sold :)

stocksforbreakfast

As a bear I TAP OUT

Pristine_Hurry_4693

In short, I’ve never seen a better risk/reward opportunity. With a market cap of only ~250M, they have 90M cash, Built factories, patented tech and many ongoing FDA approved trials some in phase 2 and 3. They also have FDA breakthrough device designation, FDA TAP program, MDSAP certification and more. Their product is a cancer treatment with 100% tumor response in early clinical trial results (hence all the approvals and FDA push), they could treat high unmet needs like pancreatic cancer, lung cancer, GBM and pretty much any tumor they can reach (their devices are built to reach inner organ tumors) and have yet to find a tumor that doesn’t respond to the treatment (dozens tested), therefore making them a potential life saving revolution in a multi hundred billion dollar market.

Greg_Coat

Is TAP a Canadian stock?  I bought some shares and some calls bc I'm an alcoholic and am wondering if it will come back with a Canada deal.

leomeng

Sold JNJ calls +6k Sold TAP calls +2.7k

No_Procedure4924

TAP corn going to $1

Any-Inspection-3325

how is it red? my portfolio is all green CPB MDLZ PEP MCD UNH STZ TAP FDX XLP

No_Procedure4924

Going to put $125 into TAP (The America Party) coin, hope Elon makes it a thing and I break even from my 1dte SPY puts on May OPEX Thurs./Fri., when it goes 1000x.

leomeng

TAP possible takeover target in July. Place your bets

Pristine_Hurry_4693

My best play is $DRTS. Usually the bigger the reward so it the risk, therefore many will miss real gains even when they hit. This stock is in a once in a lifetime position imho. With a market cap of only ~250M, the company has 90M+ cash, three factories, patented tech, FDA breakthrough device designation, FDA TAP program, FDA IDE’s, MDSAP certification and much more. One could argue the stock is fundamentally worth today more than the 3$ it’s trading at (even if no further approvals are granted). They have many FDA approved clinical trials going on, some in phase 2 and 3 already. They also past all the PMDA appliances and are expected approval in Japan this quarter. Their product is a new cancer treatment, with early clinical results showing 100% tumor response. The treatment (Alpha DaRT) can shrink tumors and make them disappear even in unmet needs cases. The treatment also showed a systemic immune response. I’d love to share more all about it if anyone would like to hear. The reason it isn’t trading around 10$ (already now, and could go much higher of course with the PMDA expected approval and then FDA and US commercialization in H1 2026) is because it has 0 PR and 0 retail exposure.

billy8008135

one don’t even get me started about the DELICIOUS FUCKING TAP WATER (why everyone’s so hot)

Pristine_Hurry_4693

Love the breakdown, thanks for sharing! I just answered your former comment and seeing this now. Worth noting $DRTS already: - Received FDA Breakthrough Device Designation - Got accepted into the FDA's Total Product Life Cycle Advisory Program (TAP) - Achieved MDSAP (Medical Device Single Audit Program) certification - Received FDA approval for an Investigational Device Exemption (IDE) - Is expecting PMDA approval in Japan this quarter - Is in phase 3 of FDA approved trials and has many more trials in other phases

nateccs

gonnna do some heavy research on these stocks this weekend: TAP PHAT ASS

ithinkitsahairball

TAP

McFistPunch

Ok then why is my TAP position fucked

Warren_Puff-it

The market isn't perfectly efficient. It's possible to identify aspects of a business/trend/set of numbers which are being overlooked and not priced in to the equity. Growth stocks may already have their growth priced in and run a higher risk, but can also, oftentimes, offer more upside in innovation and/or opportunity through the means of their business and leadership/execution. For example, a company like TAP (Molson Coors), could be seen as a value stock. - There's essentially a zero chance that the business of manufacturing and selling alcohol will disappear in our lifetimes (although it may dwindle). It's highly unlikely that a small competitor will catapult their way into a significant market share like TAP currently holds. That comes at the price of growth though - it's highly unlikely that any new form of alcohol (or another product in their portfolio) is going to come along and completely revolutionize the industry. See the rise of the alcoholic seltzer. Seltzers were an innovative product for the industry, but it's not like it had the potential to double their revenue or profits. - Strategic acquisitions aren't going to heavily move the needle either, they pretty much need to stay on top of acquisitions just to maintain some growth in-line with the industry. - Leadership is important to keep the gears turning smoothly and find efficiencies, but great leadership in this industry is focused more on keeping margins healthy without sacrificing vital business assets. Now let's look at a growth company, I'm just randomly picking Uber for this example. - Uber was just a ridesharing company at first. There's was a real possibility that the ridesharing industry didn't succeed at the rate which it was projected. They also had a very small moat, a young company could easily chip away at their market share and ruin their business plan. If the rideshare industry does take off though, then they have a plan which is poised for immense growth already. Innovation/opportunity is also likely to emerge as the industry matures as well. Think driverless cars/taxis or busses. Not only does this give them potential to increase their margins, but it could lead to a paradigm shift in auto owernship. Hypothetically, ridesharing could become much cheaper and efficient than owning and maintaining a personal vehicle and companies like Uber can capitalize on that efficiency. - Strategic acquisitions can be highly lucrative as well. Look at Uber Eats. They took their existing infrastructure and integrated a delivery service. Pizza places and smaller delivery services have been doing delivery for years, Uber was just able to make it way more accessible and easy to use, opening a huge revenue stream that no one expected when Uber was in its infancy. - Leadership also becomes much more valuable. Poor leadership wouldn't have just shrunk their margins or temporarily set them back for a year or two, poor leadership could have changed their entire company's course and they could have easily would have been killed off by competition after just a short time of under performance. Don't think of this as looking at both companies in hindsight, think of it as looking with foresight into the industries and people involved in each company. Growth stocks may be priced higher on current earnings, and run a higher risk of failure or negative returns, but they also have the opportunity for significant...growth. The market didn't look at Uber and price in the fact that driverless cars or food delivery services were going to be factors in their future, so it can't be that damn efficient.

EmbarrassedBet9801

i bet you'd TAP that ass

CallsOrPutsYES

If UNH goes down another 10% I will TAP Margin for calls

Forever_U8

Hey sub….. you just need to TAP IN….. instead of HATING on some shit that YOU DONT KNOW ABOUT. SMH. 👀🤦🏾‍♂️🤦🏾‍♂️🤦🏾‍♂️🤦🏾‍♂️🤦🏾‍♂️🤦🏾‍♂️🤦🏾‍♂️🤦🏾‍♂️😂😂

BIGDADDYHANIN

2 Rate Cuts on TAP THATS WHY WE PUMPING NERDS!

Latter-Candidate1924

I stg the market is so stupid. World economic crisis? NAH DAWG WE GOT THEM 0.25% RATE CUTS ON TAP MUHFUKKAH 

Doctor_Saved

TAP. No way people are drinking less beer in the next few years.

Drash1

I’d beg to differ. I’ve been looking at this for many years and have done years of modeling on RIO and tax implications near and far term. I’m close to retirement now and using Boldin SW as a simple guide. Having plenty of time and an interest I’ve played with the numbers and switched my Roth balances to traditional and vice versa in the model, weighting in various scenarios, etc. and long term Roth gains and tax savings far outweigh using traditional vehicles. For the short term (say someone who’s already in their 50’s and nearing the top of their earning years it’s not the same equation. As I stated above I gave a very simplified but sound answer. Something that can be posted here without writing a novel. As for 401K plans having worse fees and fewer options, that depends. My federal TSP has minuscule fees and recently mutual fund window available to go out into the broader market for a small annual fee. Sure almost everything that’s 401K/403B/TAP is going to cost a little more than a discount brokerage like Schwab or vanguard Ira and Roth, but they’re not capped as low either allowing one to put more money away annually without penalty’s.

maximuminimum

**CWAK SUCKA TURN DISPLAY TOWARDS DRIVER** 🟢🟢🟢🟢 TAP PLAID MODE !!! TSLA ABOHT TO LEAVE BERS IN THE DUST 🏎️🏎️🏎️ WINK AT HOTTy IN THE NEXT CAR , SAY HI AND BUY !!! KEEP 6 PaCK for BEST RETURN !!! Wooo woooo woooooh TSLA 270 EOM COCK & STOCK MALE PORSTATE G SPOT 🇺🇸🇺🇸🇺🇸🇺🇸☕️☕️🐎🐎🐎🐎

pandadogunited

Brewing you say? TAP calls it is.

SpongEWorTHiebOb

Missing TAP. Er tomorrow at close. It’s damn cheap.

whatislife1027

INTEL‼️‼️‼️ yall need to TAP IN

WhiskyOvrWater

You’ve never seen a PHAT AZZ? I feel bad for you PP. Maybe have someone else TAP in for a bit.

Iunatic

Am I still banbet banned  TAP PHAT AZZ PP

isolated-cat

PHAT AZZ PP TAP  make WSB great again?

Hextall2727

1. I like InTheMoney's videos on youtube. Also, read up on Scottishtrader's methodology in trading the wheel here. Take a look at r/thetagang for tips on selling options. selling options, in my opinion, is less risky than buying. buying to me seems like a lottery ticket. Note, I"m currently running a few PMCCs, which requires buying a LEAPS deep in the money. don't worry if you don't understand that... watch some videos. 2. I started paper trading on Webull. 3. I started with the wheel. It's all about selling options to collect premium. Sell a put, if it gets assigned, sell a call. collect premium. Do this on stocks you don't mind owning long term. I target stocks that pay dividends for extra income. I also use Fidelity which pays interest on the cash I set aside for the collateral selling puts. 4. mentioned above... don't trade options on things that you don't mind owning, even if the price drops a bit. quality tickers over meme stocks. Here's my wheeling strategy: \- tickers I don't mind owning, that pay dividends (KO, DVN, TAP are some examples) \- sell options that expire 30-45 days and have deltas <0.25. \- track adjusted cost basis (striek price assigned minus all the premiums I've collected in a single wheel cycle). If I have to sell a CC below my cost, make sure it's above my adjusted cost basis. \- roll for credit if CSPs or CCs approach ATM. Slow and steady is how I'm trying to turn $25k into enough of a bankroll to pay my property taxes. It likely will take a while, but my options bankroll is a small percentage of my total investment assets.

neogeomasta

TAP looks like a better pick in that sector to me

Organic-Grocery

Coors banquet is best beer. Just found out I can buy their stock, for every six pack of banquets I buy I’ll buy an equivalent amount of TAP

rocc_high_racks

TAP, BUD, etc.

nicholasCageSucks

Orange man in da house and still lost money, TAP IN! TAP TAP TAP IN!!

Classic-Finish-7433

Puts on MO, PM, DEO, STZ and TAP 🫡

xDubnine

Just saw the rock take the next steps into Hollywood stardom by wearing a dress for a commercial. The drink? ZOA. The stock ticker that distributes it? TAP. full porting into it since the devil works in mysterious ways.